Company intelligence / Profile preview

Huaren Pharmaceutical

Qingdao, Shandong, Chinaen.hrmtgroup.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company has a broad commercial portfolio with over ninety-eight drug varieties across two hundred twelve specifications. Its main products—small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices—are all manufactured under GMP standards. All production lines have passed new GMP certification. Subsidiary Stellar Pharmaceutical holds a license as one of China’s designated manufacturers of Class II psychotropic APIs.

Therapeutic areas: PulmonologyMetabolic DisordersNephrologyOther
Modalities: Small moleculeBiologicDevice
Industry: Pharma

Beyond the preview

Go deeper on Huaren Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huaren Pharmaceutical.

Explore the full profile